Literature DB >> 15639777

Gene-environment interplay in neurogenesis and neurodegeneration.

Tomás Palomo1, Trevor Archer, Richard J Beninger, Richard M Kostrzewa.   

Abstract

Factors associated with predisposition and vulnerability to neurodegenerative disorders may be described usefully within the context of gene-environment interplay. There are many identified genetic determinants for so-called genetic disorders, and it is possible to duplicate many elements of recognized human neurodegenerative disorders in either knock-in or knock-out mice. However, there are similarly, many identifiable environmental influences on outcomes of the genetic defects; and the course of a progressive neurodegenerative disorder can be greatly modified by environmental elements. Constituent cellular defense mechanisms responsive to the challenge of increased reactive oxygen species represent only one crossroad whereby environment can influence genetic predisposition. In this paper we highlight some of the major neurodegenerative disorders and discuss possible links of gene-environment interplay. The process of adult neurogenesis in brain is also presented as an additional element that influences gene-environment interplay. And the so-called priming processes (i.e., production of receptor supersensitization by repeated drug dosing), is introduced as yet another process that influences how genes and environment ultimately and co-dependently govern behavioral ontogeny and outcome. In studies attributing the influence of genetic alteration on behavioral phenotypy, it is essential to carefully control environmental influences.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15639777     DOI: 10.1007/BF03033279

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  301 in total

1.  Adult-generated hippocampal and neocortical neurons in macaques have a transient existence.

Authors:  E Gould; N Vail; M Wagers; C G Gross
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.

Authors:  A L Brody; S Saxena; P Stoessel; L A Gillies; L A Fairbanks; S Alborzian; M E Phelps; S C Huang; H M Wu; M L Ho; M K Ho; S C Au; K Maidment; L R Baxter
Journal:  Arch Gen Psychiatry       Date:  2001-07

3.  Molecular cloning and functional characterization of chicken brain tau: isoforms with up to five tandem repeats.

Authors:  Hirotaka Yoshida; Michel Goedert
Journal:  Biochemistry       Date:  2002-12-24       Impact factor: 3.162

4.  p38 kinase is activated in the Alzheimer's disease brain.

Authors:  K Hensley; R A Floyd; N Y Zheng; R Nael; K A Robinson; X Nguyen; Q N Pye; C A Stewart; J Geddes; W R Markesbery; E Patel; G V Johnson; G Bing
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

5.  Huntington disease phenocopy is a familial prion disease.

Authors:  R C Moore; F Xiang; J Monaghan; D Han; Z Zhang; L Edström; M Anvret; S B Prusiner
Journal:  Am J Hum Genet       Date:  2001-10-09       Impact factor: 11.025

Review 6.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

7.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

Authors:  R Luthi-Carter; A Strand; N L Peters; S M Solano; Z R Hollingsworth; A S Menon; A S Frey; B S Spektor; E B Penney; G Schilling; C A Ross; D R Borchelt; S J Tapscott; A B Young; J H Cha; J M Olson
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

8.  Autosomal dominant chorea-acanthocytosis with polyglutamine-containing neuronal inclusions.

Authors:  R H Walker; S Morgello; B Davidoff-Feldman; A Melnick; M J Walsh; P Shashidharan; M F Brin
Journal:  Neurology       Date:  2002-04-09       Impact factor: 9.910

9.  Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice.

Authors:  Hans-Joachim Lüth; Jenny Apelt; Amadi O Ihunwo; Thomas Arendt; Reinhard Schliebs
Journal:  Brain Res       Date:  2003-07-04       Impact factor: 3.252

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  6 in total

Review 1.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 2.  Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease.

Authors:  Rodrigo Franco; Sumin Li; Humberto Rodriguez-Rocha; Michaela Burns; Mihalis I Panayiotidis
Journal:  Chem Biol Interact       Date:  2010-06-11       Impact factor: 5.192

3.  Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise.

Authors:  Tomas Palomo; Richard J Beninger; Richard M Kostrzewa; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 4.  Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

Review 5.  Comorbidity implications in brain disease: neuronal substrates of symptom profiles.

Authors:  Tomas Palomo; Richard J Beninger; Richard M Kostrzewa; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

Review 6.  Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis.

Authors:  Afroza Khanam Irin; Alpha Tom Kodamullil; Michaela Gündel; Martin Hofmann-Apitius
Journal:  J Immunol Res       Date:  2015-11-09       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.